相关实验视频

Updated: May 24, 2025

Fear Incubation Using an Extended Fear-Conditioning Protocol for Rats

Fear Incubation Using an Extended Fear-Conditioning Protocol for Rats

Published on: August 22, 2020

在地下迷幻疗法培训计划中重复使用psilocybin的长期不良影响:一个案例报告

John Perna¹, Justin Trop¹, Roman Palitsky^1,2,3

¹Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.

|February 28, 2025

概括

迷幻疗法培训可能导致长期不良反应 (PAE),如严重的睡眠障碍和自杀念头. 及时的精神科干预,如电疗法 (ECT),对于康复至关重要,尽管与迷幻社区实践的潜在冲突.

科学领域:

精神病学是一个精神病学.
临床心理学临床心理学
神经科学是一个神经科学.

背景情况:

迷幻药辅助疗法对心理健康治疗越来越感兴趣.
心理治疗的培训计划正在出现,包括不受监管的"地下"选择.
迷幻药物使用的长期不良体验 (PAE) 了解甚少,但对研究至关重要.

研究的目的:

介绍心理治疗培训期间长时间的不良影响的案例研究.
突出精神病治疗和迷幻社区实践之间的潜在冲突.

主要方法:

一个心理学家的案例报告正在接受含有psilocybin的培训.
详细描述副作用,治疗和解决方案.

主要成果:

患者在重复使用高剂量的psilocybin后出现了严重的睡眠障碍,无情感和自杀念头.
由于教练的建议不寻求支持,精神病治疗被推迟了.
症状在电疗法 (ECT) 后消失.

结论:

这个案例说明了法律/地下迷幻训练,精神病学和新沙曼主义之间的紧张关系.
临床医生必须认识到影响患者护理和决策的潜在冲突.
意识到这些冲突对于在心理治疗培训中管理PAE至关重要.

关键词:

不良影响不良影响案例报告案例报告电疗法是一种电疗法.伦理学伦理学伦理学这种药物是psilocybin.迷幻疗法是一种心理疗法.

更多相关视频

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression

How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression

Published on: January 23, 2017

相关概念视频

CNS Stimulants: Psychedelic Agents

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

Hallucinogens and Psychedelics

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...